Pharmacy

Imerys Talc America, which supplies talc for Johnson & Johnson's baby powder, filed for Chapter 11 bankruptcy Feb. 13, according to Bloomberg.

The World Health Organization is warning patients, physicians and pharmacies about a fake cancer drug that is circulating in the U.S. and Europe, according to The Guardian.

Mylan launched its generic version of GlaxoSmithKline's asthma treatment Advair at a price 70 percent lower than the branded treatment, according to Reuters.

After several years of declining revenues, top generic drug maker Teva Pharmaceuticals will turn to high-priced biotech medications in an effort to jumpstart growth, The Wall Street Journal reports.

A federal judge has ruled that AbbVie must turn over documents in a lawsuit that accuses the drugmaker of using "unclean hands" to create a thicket of patents to protect its best-selling drug Humira from competition, according to STAT.

Ahead of the 2020 presidential race, New Jersey Democrat Sen. Cory Booker is working to shed his reputation of being a friend of the pharmaceutical industry, STAT reports.

Johnson & Johnson will shell out $3.4 billion in cash to buy robotic surgery company Auris Health, CNBC reports. 

CVS Health has unveiled three redesigned health-focused concept stores in the Houston market, according to CNBC.

The U.S. Securities and Exchange Commission told Johnson & Johnson it can choose not to hold a shareholder vote on a proposal that would send all shareholder disputes to private arbitration hearings rather than federal court, according to The Wall…

As part of a restructuring effort, Seres Therapeutics, a Cambridge, Mass.-based drugmaker developing biological treatments, will cut 30 percent of its workforce and make changes to its executive team.